Literature DB >> 21740893

Hyal2 is a glycosylphosphatidylinositol-anchored, lipid raft-associated hyaluronidase.

Benedicte Andre1, Cecile Duterme, Kris Van Moer, Jeannine Mertens-Strijthagen, Michel Jadot, Bruno Flamion.   

Abstract

The rapid turnover rate of hyaluronan (HA), the major unbranched glycosaminoglycan of the extracellular matrix, is dependent on hyaluronidases. One of them, hyaluronidase-2 (Hyal2), degrades HA into smaller fragments endowed with specific biological activities such as inflammation and angiogenesis. Yet the cellular environment of Hyal2, a purported glycosylphosphatidylinositol (GPI)-anchored protein, remains uncertain. We have examined the membrane association of Hyal2 in MDA-MB231 cancer cells where it is highly expressed and in COS-7 cells transfected with native or fluorescent Hyal2 constructs. In both cell types, Hyal2 was strongly associated with cell membrane fractions from which it could be extracted using a Triton X-114 treatment (hydrophobic phase) but not an osmotic shock or an alkaline carbonate solution. Treatment of membrane preparations with phosphatidylinositol-specific phospholipase C released immunoreactive Hyal2 into the aqueous phase, confirming the protein is attached to the membrane through a functional GPI anchor. Hyal2 transfected in COS-7 cells was associated with detergent-resistant, cholesterol-rich membranes known as lipid rafts. The cellular immunofluorescent pattern of Hyal2 was conditioned by the presence of a GPI anchor. In summary, the strong membrane association of Hyal2 through its GPI anchor demonstrated in this study using biochemical methods suggests that the main activity of this enzyme is located at the level of the plasma membrane in close contact with the pericellular HA-rich glycocalyx, the extracellular matrix, or possibly endocytic vesicles.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21740893     DOI: 10.1016/j.bbrc.2011.06.125

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  30 in total

1.  Hyaluronan Depolymerization by Megakaryocyte Hyaluronidase-2 Is Required for Thrombopoiesis.

Authors:  Aaron C Petrey; Dana R Obery; Sean P Kessler; Bruno Flamion; Carol A de la Motte
Journal:  Am J Pathol       Date:  2016-07-08       Impact factor: 4.307

2.  Platelet hyaluronidase-2 regulates the early stages of inflammatory disease in colitis.

Authors:  Aaron C Petrey; Dana R Obery; Sean P Kessler; Ash Zawerton; Bruno Flamion; Carol A de la Motte
Journal:  Blood       Date:  2019-07-01       Impact factor: 22.113

3.  Deficiency in mouse hyaluronidase 2: a new mechanism of chronic thrombotic microangiopathy.

Authors:  Cécile Onclinx; Sophie Dogne; Laurence Jadin; Fabienne Andris; Christian Grandfils; François Jouret; François Mullier; Bruno Flamion
Journal:  Haematologica       Date:  2015-05-01       Impact factor: 9.941

4.  Hyaluronidase 2 (HYAL2) is expressed in endothelial cells, as well as some specialized epithelial cells, and is required for normal hyaluronan catabolism.

Authors:  Biswajit Chowdhury; Richard Hemming; Sana Faiyaz; Barbara Triggs-Raine
Journal:  Histochem Cell Biol       Date:  2015-10-29       Impact factor: 4.304

5.  Melanoma cell-derived factors stimulate hyaluronan synthesis in dermal fibroblasts by upregulating HAS2 through PDGFR-PI3K-AKT and p38 signaling.

Authors:  Sanna Pasonen-Seppänen; Piia Takabe; Michael Edward; Leena Rauhala; Kirsi Rilla; Markku Tammi; Raija Tammi
Journal:  Histochem Cell Biol       Date:  2012-07-24       Impact factor: 4.304

6.  Hyaluronidase 2: a novel germ cell hyaluronidase with epididymal expression and functional roles in mammalian sperm.

Authors:  Mark J Modelski; Gladys Menlah; Yipei Wang; Soma Dash; Kathie Wu; Deni S Galileo; Patricia A Martin-DeLeon
Journal:  Biol Reprod       Date:  2014-09-17       Impact factor: 4.285

7.  CD44 knock-down in bovine and human chondrocytes results in release of bound HYAL2.

Authors:  Daisuke Hida; Ben T Danielson; Cheryl B Knudson; Warren Knudson
Journal:  Matrix Biol       Date:  2015-04-09       Impact factor: 11.583

Review 8.  The dynamic metabolism of hyaluronan regulates the cytosolic concentration of UDP-GlcNAc.

Authors:  Vincent C Hascall; Aimin Wang; Markku Tammi; Sanna Oikari; Raija Tammi; Alberto Passi; Davide Vigetti; Richard W Hanson; Gerald W Hart
Journal:  Matrix Biol       Date:  2014-01-30       Impact factor: 11.583

Review 9.  Emerging roles for hyaluronidase in cancer metastasis and therapy.

Authors:  Caitlin O McAtee; Joseph J Barycki; Melanie A Simpson
Journal:  Adv Cancer Res       Date:  2014       Impact factor: 6.242

10.  Epigenetic profiles of pre-diabetes transitioning to type 2 diabetes and nephropathy.

Authors:  Thomas A VanderJagt; Monica H Neugebauer; Marilee Morgan; Donald W Bowden; Vallabh O Shah
Journal:  World J Diabetes       Date:  2015-08-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.